1. Introduction {#sec1}
===============

The perinatal period in life has the highest risk for mortality \[[@bib1]\]. Annually, there is an estimated 4 million perinatal and neonatal deaths \[[@bib2], [@bib3], [@bib4]\]. Estimates show that low- and middle-income countries contribute to approximately 98% of all perinatal deaths \[[@bib2],[@bib3],[@bib5],[@bib6]\]. Because of the suboptimal vital registry infrastructure in low- and middle-income countries, it is likely that the total perinatal and neonatal deaths in these countries are even higher \[[@bib7],[@bib8]\]. The contribution of neonatal mortality to the under-five mortality has been steadily rising \[[@bib9]\] because post neonatal child mortality is decreasing faster than neonatal mortality. Home births and lack of trained neonatal care providers at birth in low- and middle-income countries are the most likely factors responsible for high perinatal and neonatal deaths \[[@bib6],[@bib10], [@bib11], [@bib12]\]. In 2009, 60 million deliveries were estimated to occur outside health facilities \[[@bib13]\]. Out of those 60 million deliveries, approximately 52 million deliveries happen without the presence of a trained birth attendant \[[@bib11],[@bib14]\]. In low- and middle-income countries health facilities are inadequately equipped and lack trained neonatal care providers \[[@bib6],[@bib15],[@bib16]\]. The limited quality of perinatal care and the neonates' inherent low capacity to compensate in adverse conditions or diseases results in high rates of neonatal mortality in low- and middle-income countries \[[@bib6],[@bib17], [@bib18], [@bib19], [@bib20], [@bib21]\]. The objective of this review is to synthesize and to evaluate the interventional and observational studies designed to assess antenatal, intrapartum, and neonatal interventions aimed to reduce perinatal and neonatal mortality in low- and middle-income countries. (see [Table 1](#tbl1){ref-type="table"})Table 1Meta-analyses focusing on interventions to reduce perinatal mortality.Table 1Period of interventionIntervention n nameYear of meta-analysisPublication year of included studiesNumber of studies includedTypes of trials includedNumber of participantsEffects studied & size (95% CI)AntenatalAntenatal care \[[@bib25]\]20182009--201718Cross sectional & case-control studies94,118 neonatesNM RR = 0.66 (0.54--0.80)Antenatal care, sub-Saharan Africa \[[@bib26]\]20192009--201912Cohort & cross-sectional studies79,990 neonatesNM RR = 0.61 (0.43--0.86)Birth interval \< 18 months \[[@bib28]\]20131982--20045Cohort studies32,670 neonatesSGA OR = 1.51 (1.31--1.75)\
Prematurity OR = 1.58 (1.19--2.10)\
NM OR = 1.49 (0.93--2.37)\
IM OR = 1.83 (1.19--2.81)Tetanus toxoid vaccination \[[@bib29]\]20101966--19982RCT & cohort study2146 neonatesNM from tetanus infection RR = 0.06 (0.02--0.2)Nutrition education \[[@bib34]\]20151973--201417RCT9030 womenPrematurity RR = 0.46 (0.21--0.98)\
LBW RR = 0.04 (0.01--0.14)Iron supplementation \[[@bib35]\]20151947--201261RCT & quasi-RCT43,274 womenLBW RR = 0.84 (0.69--1.03)\
Prematurity RR = 0.93 (0.84--1.03)\
NM RR = 0.91 (0.71--1.18)Vitamin A supplementation \[[@bib36]\]20151993--201119RCT, quasi-RCT, & cluster RCT310,000 womenPM RR = 1.01 (0.95--1.07)\
NM RR = 0.98 (0.94--1.01)Vitamin C supplementation \[[@bib37]\]20151966--201429RCT & quasi-RCT24,300 womenSB RR = 1.15 (0.89--1.49)\
PM RR = 1.07 (0.77--1.49)\
NM RR = 0.79 (0.58--1.08)Vitamin D supplementation \[[@bib38]\]20191980--201730RCT, quasi-RCT, & cluster RCT7033 womenPrematurity RR = 0.66 (0.34--1.34)\
LBW RR = 0.55 (0.35--0.87)Multi-micronutrient supplementation \[[@bib39]\]20191975--201421RCT142,496 womenVery preterm neonates RR = 0.81(0.71--0.93)\
SGA RR = 0.92 (0.88--0.97)\
LBW RR = 0.88 (0.85--0.91)\
Prematurity RR = 0.95 (0.90--1.01)\
SB RR = 0.95 (0.86--1.04)\
PM RR = 1.00 (0.90--1.11)\
NM RR = 1.00 (0.89--1.12)DeliveryBasic neonatal resuscitation \[[@bib42]\]20111985--201124Observational, quasi-experimental, & cluster RCT392,506 neonatesIntrapartum-related deaths RR = 0.70 (0.59--0.84)Basic neonatal resuscitation \[[@bib43]\]20171990--201620RCT, quasi-RCT, interrupted time series, & before--after studies1,653,805 neonatesSB RR = 0.79 (0.44--1.41)\
7-day NM RR = 0.53 (0.38--0.73)\
28-day NM RR = 0.50 (0.37--0.68)\
PM RR = 0.63 (0.42--0.94)Skilled birth attendant \[[@bib45]\]20111989--200821Pre-post cohort studiesNot mentionedSB RR = 0.77 (0.69--0.85)Clean delivery practices \[[@bib46]\]20111991--201038Case-control & cohort studiesNot mentionedProvider handwashing & NM RR = 0.19 (0.01--0.34)\
Maternal handwashing\
& NM RR = 0.44 (0.18--0.62)Health facility delivery \[[@bib59]\]20131996--201219Cohort & cross-sectional studies1,606,805 neonatesNM RR = 0.71 (0.54--0.87)Health facility delivery \[[@bib60]\]20192010--201719Cohort & cross-sectional studies1,046,362 neonatesNM OR = 0.48 (0.38--0.58)Post Delivery & NeonatalUmbilical cord chlorhexidine application \[[@bib61]\]20162006--20136RCT, quasi-RCT, & cluster RCT59,179 neonatesNM RR = 0.85 (0.76--0.95)\
Omphalitis RR = 0.71 (0.62--0.81)Exclusive breastfeeding \[[@bib62]\]20151982--201111Observational studies70,976 neonatesNM OR = 3.67 (2.04--6.61)Kangaroo mother care \[[@bib63]\]20161988--201621RCT3041 neonatesNM RR = 0.60 (0.39--0.92)\
Sepsis RR = 0.35 (0.22--0.54)\
Hypothermia RR = 0.28 (0.16--0.49)Kangaroo mother care \[[@bib64]\]20161988--2014124RCT & observational studiesNot mentionedNM RR = 0.64 (0.46--0.89)\
Sepsis RR = 0.53 (0.34--0.83)\
Hypothermia RR = 0.22 (0.12--0.41)Combined Antenatal &PostnatalEducation \[[@bib65]\]20191995--201733RCT, quasi-RCT, & cluster RCTNot mentionedNM RR = 0.87 (0.78--0.96)\
Early NM RR = 0.74 (0.66--0.84)\
Late NM RR = 0.54 (0.40--0.74)\
PM RR = 0.83 (0.75--0.91)Education \[[@bib66]\]20112008--20114RCT57270 neonatesNM OR = 0.81 (0.75--0.88)\
Early NM OR = 0.80 (0.70--0.91)\
Late NM OR = 0.79 (0.63--0.99)Education \[[@bib67]\]20172001--201717Cluster-RCTNot mentionedNM RR = 0.75 (0.69--0.80)Home based antenatal & neonatal care \[[@bib69]\]20162008--20125Cluster-RCT101,655 neonatesNM RR = 0.75 (0.61--0.92)\
PM RR = 0.78 (0.64--0.94)[^1]

2. Antenatal interventions {#sec2}
==========================

2.1. Antenatal care {#sec2.1}
-------------------

Antenatal care has been shown to be associated with improved perinatal outcomes in low- and middle-income countries \[[@bib22],[@bib23]\]. In a study based on cross-sectional data from 57 low- and middle-income countries (N = 464,728), regular antenatal care was associated with a lower risk of neonatal mortality (HR = 0.45, 95% CI = 0.42--0.48) \[[@bib24]\]. In a meta-analysis of cross sectional and case-control studies, antenatal care was found to be associated with a lower in neonatal mortality (RR = 0.66, 95% CI 0.54--0.80) \[[@bib25]\]. In a meta-analysis of cohort and cross-sectional studies only from sub-Saharan Africa, antenatal care was found to be associated with a lower in neonatal mortality (RR = 0.61, 95% CI 0.43--0.86) \[[@bib26]\], There has not been a meta-analysis of comprehensive antenatal care in low- and middle-income countries. However, improved antenatal care and a program of emergency obstetric and neonatal care did not reduce perinatal or neonatal mortality in a recent large and well-conducted randomized controlled trial \[[@bib27]\].

2.2. Birth interval {#sec2.2}
-------------------

Increasing the birth interval between pregnancies is associated with less adverse neonatal outcomes. In a meta-analysis assessing cohort studies of birth interval, birth interval \<18 months was associated with a higher risk of small for gestational age (aOR = 1.51, 95% CI 1.31--1.75), prematurity (aOR = 1.58, 95% CI = 1.19--2.10), neonatal mortality (aOR = 1.49, 95% CI 0.93--2.37) and infant mortality (aOR = 1.83, 95% CI = 1.19--2.81) \[[@bib28]\].

2.3. Tetanus toxoid vaccination {#sec2.3}
-------------------------------

In a meta-analysis based on one randomized controlled trial and one cohort study to assess the effect of tetanus vaccination on neonatal mortality, two doses of tetanus vaccine administered to the mother before delivery reduced neonatal mortality from tetanus infection (RR = 0.06 95% CI 0.02--0.2) \[[@bib29]\].

2.4. Antenatal corticosteroids {#sec2.4}
------------------------------

Evidence from many well-designed randomized controlled clinical trials conducted in higher-income countries and the respective meta-analyses indicate that antenatal corticosteroids reduce neonatal mortality and major morbidities \[[@bib30]\]. Data on the effect of antenatal corticosteroids on preterm neonatal outcomes from low-income countries are limited. In a multi-country cluster randomized controlled trial of antenatal corticosteroids in women at high risk of preterm delivery (N = 98,137), 28-day neonatal mortality increased in the antenatal steroid group compared to the control group (RR 1.12, 1.02--1.22, *P* = .0127). Furthermore, there was an increased incidence of suspected maternal infection in the antenatal steroid group (OR = 1.45, 95% CI = 1.33--1.58, *P* \< .0001) \[[@bib31]\]. The ongoing trial of antenatal corticosteroid and its impact on perinatal outcomes from low-income countries will help in further understanding the role of antenatal corticosteroids on outcomes \[[@bib32]\].

2.5. Antenatal ultrasound {#sec2.5}
-------------------------

A multi-country cluster-randomized controlled trial from low-income countries of two antenatal ultrasound assessments in addition to standard care showed no significant difference in antenatal care coverage, hospital delivery of complicated pregnancies, or composite outcome of adverse perinatal outcomes including stillbirth and neonatal mortality \[[@bib33]\].

2.6. Antenatal nutrition {#sec2.6}
------------------------

A meta-analysis of randomized controlled trials of antenatal nutritional education and perinatal outcomes showed that antenatal nutrition education decreased preterm birth (RR = 0.46, 95% CI = 0.21--0.98) and low birth weight (RR = 0.04, 95% CI = 0.01--0.14). Other perinatal outcomes did not differ between the two groups \[[@bib34]\]. A meta-analysis of randomized controlled and quasi-randomized controlled trials assessing antenatal iron supplementation and pregnancy outcomes showed that antenatal iron supplementation was associated with a trend towards the decreased risk of low birth weight (RR = 0.84, 95% CI 0.69--1.03), prematurity (RR = 0.93, 95% CI 0.84--1.03), and neonatal mortality (RR = 0.91, 95% CI 0.71--1.18) \[[@bib35]\]. A meta-analysis of randomized controlled, quasi-randomized controlled, and cluster randomized controlled trials showed that antenatal vitamin A supplementation did not impact perinatal (RR = 1.01, 95% CI 0.95--1.07) or neonatal mortality (RR = 0.98, 95% CI 0.94--1.01) \[[@bib36]\]. In a meta-analysis of randomized controlled and quasi-randomized controlled trials of antenatal vitamin C supplementation and perinatal outcomes, vitamin C was not found to be associated with any significant impact on stillbirth (RR = 1.15, 95% CI 0.89--1.49), perinatal mortality (RR = 1.07, 95% CI 0.77--1.49), and neonatal mortality (RR = 0.79, 95% CI 0.58--1.08) \[[@bib37]\]. A meta-analysis of randomized controlled, quasi-randomized controlled, and cluster randomized controlled trials showed that vitamin D supplementation had no effect on preterm birth (RR = 0.66, 95% CI 0.34--1.34) but was associated with decrease in low birth weight (RR = 0.55, 95% CI 0.35--0.87). However, vitamin D with calcium supplementation was associated with increased prematurity (RR = 1.57, 95% CI 1.01--2.28) \[[@bib38]\]. In another meta-analysis of randomized controlled trials assessing the effect of multi-micro nutrient supplementation on pregnancy outcomes, multi-micro nutrient supplementation was associated with reduction in very preterm neonates (RR = 0.81, 95% CI 0.71--0.93), small for gestation age (RR = 0.92, 95% CI 0.88--0.97), and low birth weight (RR = 0.88, 95% CI 0.85--0.91). Multi-micro nutrient supplementation was associated with a trend of reduced prematurity (RR = 0.95, 95% CI 0.90--1.01) and stillbirth (RR = 0.95, 95% CI 0.86--1.04). Multi-micro nutrient supplementation did not decrease perinatal (RR = 1.00, 95% CI 0.90--1.11) and neonatal mortality (RR = 1.00, 95% CI 0.89--1.12) \[[@bib39]\].

2.7. Genitourinary tract infection screening and treatment {#sec2.7}
----------------------------------------------------------

Genitourinary tract infection screening is being widely adopted in developed countries. A meta-analysis of randomized controlled trials showed that treatment of asymptomatic genitourinary infection reduced low birth weight births (adjusted RR, aRR = 0.64, 95% CI 0.45--0.93) and prematurity (RR = 0.27, 95% CI 0.11--0.62) \[[@bib40]\]. However, the quality of evidence in this meta-analysis was deemed low for both outcomes because all fourteen studies included in the meta-analysis were from 1960 to 1987. Furthermore, the description of the methods was not clear. All studies had high or unclear risk of bias \[[@bib40]\]. However, a recent cluster-randomized controlled trial antenatal genitourinary tract infection screening from a low-income country reported no difference in prematurity (RR = 1.07, 95% CI 0.91--1.24) \[[@bib41]\].

3. Labor and delivery intervention {#sec3}
==================================

3.1. Basic neonatal resuscitation {#sec3.1}
---------------------------------

A meta-analysis of observational, quasi-experimental, and cluster randomized controlled trials in resource-limited settings showed that basic neonatal resuscitation decreased intrapartum-related deaths (RR = 0.70, 95% CI 0.59--0.84) \[[@bib42]\]. Another meta-analysis of randomized, quasi-randomized controlled trials, interrupted time series studies, and before--after studies showed that basic neonatal resuscitation training decreased in stillbirths (RR = 0.79, 95% CI 0.44--1.41), 7-day neonatal mortality (RR = 0.53, 95% CI 0.38--0.73), 28-day neonatal mortality (RR = 0.50, 95% CI 0.37--0.68), and perinatal mortality (RR = 0.63, 95% CI 0.42--0.94). The meta-analysis of pre- and post-neonatal resuscitation training studies including an active baseline study showed that neonatal resuscitation training was associated with lower rates of stillbirths (RR = 0.88, 95% CI 0.83--0.94), fresh stillbirths (RR = 0.74, 95% CI 0.61--0.90), 1-day neonatal mortality (RR = 0.58, 95% CI 0.42--0.82), 7-day neonatal mortality (RR = 0.82, 95% CI 0.73--0.93), and perinatal mortality (RR = 0.82, 95% CI 0.74--0.91) \[[@bib43]\].

A systematic review of cohort pre-post design trials showed that implementation of Helping Babies Breathe was associated with a significant decrease in perinatal mortality (RR = 0.75, p \< 0.001), intrapartum-related stillbirths (RR 0.31--0.76), 1-day neonatal mortality (RR 0.37--0.67), and 7-day neonatal mortality (RR 0.32) \[[@bib44]\].

3.2. Presence of skilled birth attendant at delivery {#sec3.2}
----------------------------------------------------

A meta-analysis of pre-post cohort design trials showed that the presence of a skilled birth attendant in the delivery was associated with a reduction in stillbirths (RR = 0.77, 95% CI 0.69--0.85) \[[@bib45]\].

3.3. Clean delivery and resuscitation practice {#sec3.3}
----------------------------------------------

A meta-analysis of case-control and cohort studies of clean delivery and neonatal care practice, resuscitation provider handwashing (19%, 95% CI 1--34%), maternal handwashing (44%, 95% CI 18--62%), clean delivery (at home (15%, IQR 10--20%) or in a facility (27%, IQR 24--36)), and clean after birth practices (40%, IQR 25--50%) were found to be associated with a lower neonatal mortality \[[@bib46]\].

3.4. Delayed cord clamping {#sec3.4}
--------------------------

Delayed cord clamping is beneficial for both term (increased iron stores, decreased risk of anemia) and preterm neonates (reduction in mortality, reduction in the risk for anemia and blood transfusion requirement, improved hemodynamic stability, and reduction in the incidence of intraventricular hemorrhage and necrotizing enterocolitis) \[[@bib47], [@bib48], [@bib49], [@bib50], [@bib51], [@bib52]\]. Being a simple and effective intervention, delayed cord clamping has been recommended in all major basic neonatal resuscitation guidelines (\[[@bib53], [@bib54], [@bib55], [@bib56], [@bib57], [@bib58]\]).

3.5. Health facility delivery {#sec3.5}
-----------------------------

Two meta-analyses of cohort and cross-sectional studies showed that health facility delivery was associated with a lower neonatal mortality as compared to home delivery (RR = 0.71, 95% CI 0.54--0.87) (59) and (OR = 0.48, 95% CI 0.38--0.58) \[[@bib60]\].

4. Post-delivery and neonatal interventions {#sec4}
===========================================

4.1. Umbilical cord chlorhexidine application {#sec4.1}
---------------------------------------------

A meta-analysis based on randomized controlled, quasi-randomized controlled, and cluster randomized controlled trials showed that application of chlorhexidine on the umbilical cord decreased neonatal mortality (RR = 0.85, 95% CI 0.76--0.95) and omphalitis (RR = 0.71, 95% CI 0.62--0.81) \[[@bib61]\].

4.2. Exclusive breastfeeding {#sec4.2}
----------------------------

A meta-analysis of observational studies of breastfeeding and perinatal outcomes showed that exclusive breastfeeding was associated with a lower neonatal mortality (OR for non-exclusively breastfeeding = 3.67, 95% CI 2.04--6.61) \[[@bib62]\].

4.3. Kangaroo mother care {#sec4.3}
-------------------------

A meta-analysis of randomized controlled trials showed that kangaroo mother care decreased neonatal mortality (RR = 0.60, 95% CI 0.39--0.92), sepsis (RR = 0.35, 95% CI 0.22--0.54), and hypothermia (RR = 0.28, 95% CI 0.16--0.49) \[[@bib63]\]. Another meta-analysis of randomized controlled trials and observational studies showed that kangaroo mother care in low birth weight neonates decreased neonatal mortality (RR = 0.64, 95% CI 0.46--0.89), sepsis (RR = 0.53, 95% CI 0.34--0.83), and hypothermia (RR = 0.22, 95% CI 0.12--0.41) \[[@bib64]\].

5. Interventions focusing on antenatal and postnatal periods {#sec5}
============================================================

5.1. Education {#sec5.1}
--------------

A meta-analysis of randomized controlled, quasi-randomized, and cluster-randomized controlled trials showed that community health educational interventions decreased neonatal mortality (RR = 0.87, 95% CI 0.78--0.96), early neonatal mortality (RR = 0.74, 95% CI 0.66--0.84), late neonatal mortality (RR = 0.54, 95% CI 0.40--0.74), and perinatal mortality (RR = 0.83, 95% CI 0.75--0.91) \[[@bib65]\]. A meta-analysis of randomized controlled trials found that community-based behavioural interventions reduced neonatal mortality (aOR = 0.81, 95% CI 0.75--0.88), early neonatal mortality (aOR = 0.80, 95% CI 0.70--0.91), and late neonatal mortality (aOR = 0.79, 95% CI 0.63--0.99) \[[@bib66]\]. In another meta-analysis of cluster-randomized trials, community-based interventions reduced neonatal mortality (RR = 0.75, 95% CI 0.69--0.80) \[[@bib67]\].

5.2. mHealth interventions {#sec5.2}
--------------------------

A meta-analysis based on randomized controlled and quasi-experimental trials showed that mHealth interventions increased antenatal care (MD = 0.67, 95% CI = 0.35--0.99) and postnatal care (OR = 1.36, 95% CI = 1.00--1.85), but their effect on neonatal mortality was not adequately reported \[[@bib68]\].

5.3. Home based antenatal and neonatal care {#sec5.3}
-------------------------------------------

A meta-analysis of cluster-randomized trials showed that home-based antenatal and neonatal care reduced neonatal mortality (RR = 0.75, 95% CI 0.61--0.92) and perinatal mortality (RR = 0.78, 95% CI 0.64--0.94) \[[@bib69]\]. 9 ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Interventions and their effect on neonatal mortality. Not included in the Forest Plot are the meta-analysis that assessed individual cause specific mortality and those with unclear participant size. RR = risk ratio, OR = odds ratio.Fig. 1

6. Conclusion {#sec6}
=============

Many effective interventions are associated with reduced neonatal mortality. Evidence-based interventions that improve neonatal survival should be scaled up to reduce preventable perinatal deaths. Given the magnitude of perinatal and neonatal mortality burden in low- and middle-income countries and existing gaps in healthcare availability and utilization, focused and quality interventional trials are needed to elucidate further interventions that might be of the highest benefit for improving neonatal survival. Packages of care focused on groups of interventions from pre-pregnancy to postnatal care with concurrent capacity building of local health infrastructure could identify the strategies to optimize the reduction of preventable deaths.
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[^1]: SGA = small for gestational age, LBW = low birth weight, SB = stillbirth, PM = perinatal mortality, NM = neonatal mortality, IM = infant mortality, OR = odds ratio, RR = risk ratio.
